English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Danish medtech firm OSAA Innovation brings connected IV solutions to WHX Dubai 2026
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

How multi-touch attribution changes ROI for healthcare marketers
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

American Lung Association applauds new federal health funding supporting CDC and NIH
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Lilly reports strong Q4 results as Mounjaro and Zepbound drive revenue growth
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Pfizer releases early Metsera obesity drug data; FDA decisions expected on key therapies
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Amgen highlights extended dosing potential for obesity drug MariTide
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Amgen declines FDA request to withdraw rare disease drug Tavneos
+ Pharmaceuticals
Patient Daily | Feb 6, 2026

Novartis maintains acquisition focus while reporting strong financial results

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones